Aclaris updates corporate presentation; no specific financial or pipeline news disclosed

Aclaris Therapeutics, Inc.

Company furnished an updated corporate overview presentation on April 14, 2023.
Presentation titled 'Empowering Patients Through Kinome Innovation' emphasizes kinase-focused pipeline.
No material new data on drug candidates, financials, or regulatory milestones in the disclosed exhibit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.